Has the name PCOS run its course?

Samuel H Myers¹, Gianpiero Forte¹, Vittorio Unfer^{2

3}

Affiliations

¹ R&D Department, Lo.Li Pharma, Rome, Italy.
² UniCamillus - Saint Camillus International University of Health Sciences, Rome, Italy. vunfer@gmail.com.
³ The Experts Group on Inositol in Basic and Clinical Research and on PCOS (EGOI-PCOS), Rome, Italy, 00161. vunfer@gmail.com.

Editorial

Samuel H Myers et al. Arch Gynecol Obstet. 2024 Sep.

. 2024 Sep;310(3):1761-1762.

doi: 10.1007/s00404-024-07571-6. Epub 2024 Jun 5.

Samuel H Myers¹, Gianpiero Forte¹, Vittorio Unfer^{2

3}

¹ R&D Department, Lo.Li Pharma, Rome, Italy.
² UniCamillus - Saint Camillus International University of Health Sciences, Rome, Italy. vunfer@gmail.com.
³ The Experts Group on Inositol in Basic and Clinical Research and on PCOS (EGOI-PCOS), Rome, Italy, 00161. vunfer@gmail.com.

Erratum in

Correction: Has the name PCOS run its course?
Myers SH, Forte G, Unfer V. Myers SH, et al. Arch Gynecol Obstet. 2024 Sep;310(3):1763. doi: 10.1007/s00404-024-07622-y. Arch Gynecol Obstet. 2024. PMID: 38977441 No abstract available.

No abstract available

Keywords: Hyperandrogenism; Normoandrogenic; PCOS; Polycystic ovary syndrome; Rotterdam criteria.

1. Stein IF, Leventhal ML (1935) Amenorrhea associated with bilateral polycystic ovaries. Am J Obstet Gynecol 29:181–191. https://doi.org/10.1016/S0002-9378(15)30642-6 - DOI
1. Bulsara J et al (2021) A review: brief insight into polycystic ovarian syndrome. Endocr Metab Sci 3:100085. https://doi.org/10.1016/j.endmts.2021.100085 - DOI
1. Norman RJ et al (2023) “Tis but thy name that is my enemy”-the problem with the naming of polycystic ovary syndrome. Fertil Steril 120:249–250. https://doi.org/10.1016/j.fertnstert.2023.03.028 - DOI - PubMed
1. The Rotterdam ESHRE/ASRM‐sponsored PCOS consensus workshop group (2003) Revised consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 19:41–47. https://doi.org/10.1093/humrep/deh098 - DOI
1. Teede HJ et al (2023) Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome†. Fertil Steril 120:767–793. https://doi.org/10.1016/j.fertnstert.2023.07.025 - DOI - PubMed